Status:
COMPLETED
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease
Lead Sponsor:
University of Miami
Collaborating Sponsors:
Hoffmann-La Roche
Conditions:
Crohn's Disease
Ulcerative Colitis
Eligibility:
All Genders
18-70 years
Brief Summary
An increase prevalence of CMV, EBV and or HHV-6 in diseased tissue of inflammatory bowel disease would suggest a role for these viruses in the etiology and/or exacerbation of IBD, whereas their absenc...
Detailed Description
The protocol is designed to evaluate the following objectives: 1. The prevalence of cytomegalovirus, Epstein Barr virus and human herpes 6 virus DNA in inflamed intestinal mucosa of patients with Cro...
Eligibility Criteria
Inclusion
- Documented, signed and dated informed consent to participate in this trial prior to any study related procedures being performed.
- Participants, male or female, aged 18-70, identified as having Crohn's colitis, UC and patients undergoing biopsy for other inflammatory disorders (non specific colitis) and for suspected intestinal malignancy.
Exclusion
- Known human immunodeficiency virus (HIV) infection
- Post organ transplant patients.
Key Trial Info
Start Date :
April 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT00222378
Start Date
April 1 2005
End Date
June 1 2012
Last Update
July 30 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jackson Memorial Hospital
Miami, Florida, United States, 33136